These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10621920)

  • 1. Focus on quetiapine.
    Green B
    Curr Med Res Opin; 1999; 15(3):145-51. PubMed ID: 10621920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group.
    Arvanitis LA; Miller BG
    Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine. A review of its use in the management of schizophrenia.
    Cheer SM; Wagstaff AJ
    CNS Drugs; 2004; 18(3):173-99. PubMed ID: 14871161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia.
    Copolov DL; Link CG; Kowalcyk B
    Psychol Med; 2000 Jan; 30(1):95-105. PubMed ID: 10722180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the effects of quetiapine ('seroquel') and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment. PRIZE Study Group.
    Emsley RA; Raniwalla J; Bailey PJ; Jones AM
    Int Clin Psychopharmacol; 2000 May; 15(3):121-31. PubMed ID: 10870870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of quetiapine and its clinical applications in schizophrenia.
    Kasper S; Müller-Spahn F
    Expert Opin Pharmacother; 2000 May; 1(4):783-801. PubMed ID: 11249516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine: efficacy and tolerability in schizophrenia.
    Kasper S; Tauscher J; Heiden A
    Eur Neuropsychopharmacol; 2001 Oct; 11 Suppl 4():S405-13. PubMed ID: 11587888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quetiapine for schizophrenia.
    Srisurapanont M; Disayavanish C; Taimkaew K
    Cochrane Database Syst Rev; 2000; (2):CD000967. PubMed ID: 10796560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of quetiapine in adolescents with schizophrenia investigated in a 6-week, double-blind, placebo-controlled trial.
    Findling RL; McKenna K; Earley WR; Stankowski J; Pathak S
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):327-42. PubMed ID: 23083020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroquel (ICI 204 636), a putative "atypical" antipsychotic, in schizophrenia with positive symptomatology: results of an open clinical trial and changes of neuroendocrinological and EEG parameters.
    Wetzel H; Szegedi A; Hain C; Wiesner J; Schlegel S; Benkert O
    Psychopharmacology (Berl); 1995 May; 119(2):231-8. PubMed ID: 7659771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical-claims databases in the design of a health-outcomes comparison of quetiapine ('Seroquel') and usual-care antipsychotic medication.
    Hong WW; Rak IW; Ciuryla VT; Wilson AM; Kylstra JW; Meltzer HY; Carpenter WT; Lehman A; Arvanitis LA
    Schizophr Res; 1998 Jun; 32(1):51-8. PubMed ID: 9690334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quetiapine: a review of its safety in the management of schizophrenia.
    Dev V; Raniwalla J
    Drug Saf; 2000 Oct; 23(4):295-307. PubMed ID: 11051217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
    Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
    Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quetiapine: a new atypical antipsychotic.
    Misra LK; Erpenbach JE; Hamlyn H; Fuller WC
    S D J Med; 1998 Jun; 51(6):189-93. PubMed ID: 9646717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of bd and tid dose regimens of quetiapine (Seroquel) in the treatment of schizophrenia.
    King DJ; Link CG; Kowalcyk B
    Psychopharmacology (Berl); 1998 May; 137(2):139-46. PubMed ID: 9630000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia.
    Peuskens J; Link CG
    Acta Psychiatr Scand; 1997 Oct; 96(4):265-73. PubMed ID: 9350955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The health economic implications of treatment with quetiapine: an audit of long-term treatment for patients with chronic schizophrenia.
    Lynch J; Morrison J; Graves N; Meddis D; Drummond MF; Hellewell JS
    Eur Psychiatry; 2001 Aug; 16(5):307-12. PubMed ID: 11514134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.